Harry Glorikian serves as Executive at Interpace Diagnostics Group, Inc., where they oversee executive responsibilities. Since joining the company, Harry Glorikian has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 3, 2016 involved receiving (via award) 127,696 shares valued at $60.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 3, 2016 | IDXG | $60.0K | Award | 127,696 | $0.47 | Discretionary |
Harry Glorikian currently holds 127,696 shares of Interpace Diagnostics Group, Inc. (IDXG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harry Glorikian has been a net neutral trader of IDXG stock. They have purchased $0 and sold $0 worth of shares.
Harry Glorikian's most recent insider trade was on Feb 3, 2016, when they sold 127,696 shares at $0.47 per share.
Get notified when new Form 4 filings are submitted